The Δ- catenin peptide vaccine stimulates the activation of cytotoxic T lymphocytes (CTL) and enhances the invasion of CD8+ T cells into the tumor. In addition, Δ- catenin peptide vaccine can enhance the secretion of IFN-γ and the killing effect of T cells on tumor cells. The gene discussed is CD8A; the disease is neoplasm.